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Abstract 
Histidine-rich glycoprotein (HRG) is an abundant multi-functional protein that is present 
in the plasma of many vertebrates. HRG has a multi-domain structure that allows the 
molecule to interact with many ligands including heparin, heparan sulfate (HS), Fcy 
receptors (FcyR), plasminogen, fibrinogen, IgG, Clq, haem and Zn2+. The ability of 
HRG to interact with various ligands simultaneously has suggested that HRG can act as 
an adaptor molecule and regulate numerous biological processes such as immune 
complex/necrotic cell/pathogen clearance, cell adhesion, angiogenesis, coagulation and 
fibrinolysis. Although HRG is thought to play an important role in both immunity and 
vascular biology, the molecular mechanisms underpinning its action remain largely 
undefined. Thus, the aim of this thesis was to characterize the molecular components 
that are involved in HRG-mediated uptake of necrotic cells and to further examine the 
role of HRG in regulating degradative enzymes, such as plasminogen/plasmin and 
heparanase. 
Studies outlined in Chapter 3 using a variety of techniques, including flow cytometry, 
ELISA and Western blotting, demonstrated that a complex consisting of both HRG and 
IgG is necessary to aid the phagocytosis of necrotic cells by the monocyte cell line 
THP-l. This process of necrotic cell uptake was found to be predominantly FcyRI- and 
HS-dependent. Intriguingly, results from direct binding experiments showed that HRG 
can potentially interact with both phospholipids and phosphorylated proteins exposed in 
necrotic cells. Furthermore, necrotic cell uptake enhanced by plasma-derived HRG also 
induced the release of pro-inflammatory cytokines such as IL-8 and TNF by THP-l 
cells. Collectively, these data suggest that HRG has the unique property of complexing 
with IgG and initiating a pro-inflammatory innate immune response that promotes the 
clearance of necrotic cells at sites of tissue injury. 
Chapter 4 describes experiments that investigated the proteolytic cleavage of human 
HRG by plasmin in detail and the effect of plasmin cleavage on various functions of 
HRG. SDS-PAGE and Western blotting studies revealed that HRG fragments generated 
xx 
by plasmin cleavage are held together by disulfide bonds and are not released from the 
HRG molecule under non-reducing conditions. Using flow cytometry- and ELISA-based 
binding studies, plasmin cleavage was found to reduce HRG binding to cell surface HS, 
but enhanced HRG binding to necrotic cells and to plasminogen immobilized on ELISA 
plates. However, both intact and plasmin-cleaved HRG enhanced plasminogen binding 
to heparin coated surfaces to a similar extent. Furthermore, the presence of heparin, Zn2+ 
or acidic pH was demonstrated to protect HRG from plasmin cleavage. Based on these 
results, proteolytic cleavage of HRG by plasmin may provide a feedback mechanism to 
regulate the effects of HRG on the plasminogen/plasmin system, as well as other 
functions ofHRG. 
Lastly, Chapter 6 describes experiments designed to examine the ability of HRG to 
interact with human platelet-derived heparanase, an endo-J3-glucuronidase that mediates 
the degradation of HS. ELISA studies demonstrated the direct binding of HRG to 
heparanase and showed that this interaction can be modulated by pH and the presence of 
hemin, heparin, HS, cardiolipin and the HS mimetic, PI-88. Using flow cytometry-based 
cell surface binding studies, HRG was also shown to modulate heparanase binding to 
cell surface receptors. Interestingly, heparanase enzymatic activity, at a range of pHs, 
was substantially enhanced by HRG. Based on these data, the direct interaction between 
HRG and heparanase can regulate the function of heparanase, potentially during both 
normal and pathological situations. 
In summary, the studies presented in this thesis have delineated the molecular 
mechanisms underlying necrotic cell removal mediated by plasma-derived HRG and 
may have important implications for the development of autoimmune disease caused by 
defective clearance of dying/dead cells. In addition, the ability of HRG to regulate 
degradative enzymes, such as plasmin and heparanase, further supports the view that 
HRG may play an important role in angiogenesis, leukocyte migration and cancer 
metastasis. 
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